Sector ratings Celon Pharma S.A. BOERSE MUENCHEN

Stocks

Real-time BOERSE MUENCHEN Other stock markets 10:14:20 11/06/2026 pm IST			5-day change	1st Jan Change
4.930 ^EUR	+0.31%		+3.69%	+5.47%

21/05	Celon Pharma Q1 net profit at 162.6 mln zlotys	RE
21/05	Celon Pharma S.A. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Global Valuation
CELON PHARMA S.A.	31Cr	-	-		-
ELI LILLY AND COMPANY	1,01300Cr		A
JOHNSON & JOHNSON	57TCr		BBB
ABBVIE INC.	40TCr	-	AA	-	-
ROCHE HOLDING AG	32TCr		AA
ASTRAZENECA PLC	28TCr		A
NOVARTIS AG	27TCr		AAA
AMGEN INC.	18TCr		A
NOVO NORDISK A/S	19TCr		A
GILEAD SCIENCES, INC.	15TCr		AA
PFIZER INC.	15TCr		A
BRISTOL-MYERS SQUIBB COMPANY	11TCr		A
VERTEX PHARMACEUTICALS INCORPORATED	11TCr		AA
SANOFI	11TCr		AA
GSK PLC	10TCr		AA
CHUGAI PHARMACEUTICAL CO., LTD.	7.75TCr		AA
TAKEDA PHARMACEUTICAL COMPANY LIMITED	4.99TCr		AA
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD	4.59TCr		AA
BAYER AG	4.01TCr		AA
TEVA PHARMACEUTICAL INDUSTRIES LIMITED	3.91TCr		-
Average	22.21TCr		AA
Weighted average by Cap.			AA